KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Current Taxes (2016 - 2022)

Pacira BioSciences (PCRX) has 9 years of Current Taxes data on record, last reported at $11000.0 in Q2 2022.

  • For Q2 2022, Current Taxes changed N/A year-over-year to $11000.0; the TTM value through Jun 2022 reached $11000.0, changed N/A, while the annual FY2021 figure was $429000.0, 276.32% up from the prior year.
  • Current Taxes reached $11000.0 in Q2 2022 per PCRX's latest filing, down from $863000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $1.7 million in Q1 2020 and bottomed at $11000.0 in Q2 2022.
  • Average Current Taxes over 5 years is $534200.0, with a median of $343000.0 recorded in 2019.
  • The widest YoY moves for Current Taxes: up 1970.51% in 2020, down 91.45% in 2020.
  • A 5-year view of Current Taxes shows it stood at $90000.0 in 2018, then surged by 1381.11% to $1.3 million in 2019, then crashed by 91.45% to $114000.0 in 2020, then soared by 276.32% to $429000.0 in 2021, then crashed by 97.44% to $11000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Current Taxes were $11000.0 in Q2 2022, $863000.0 in Q1 2022, and $429000.0 in Q4 2021.